(Hypertension. 1997;29:1344-1350.)
© 1997 American Heart Association, Inc.
Articles |
From Instituto de Química y Fisicoquímica Biológicas (UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires (M.M.G.), and Instituto de Investigaciones Farmacológicas (CONICET), Buenos Aires, Argentina.
Correspondence to Dr Edda Adler-Graschinsky, Instituto de Investigaciones Farmacológicas, Junín 956, 5o piso, Buenos Aires (1113), Argentina. E-mail eadler{at}huemul.ffyb.uba.ar
Abstract In rat atria isolated with their
cardioaccelerans nerves and labeled with
[3H]norepinephrine, exposure to
1x10-7 mol/L angiotensin II (Ang
II) and 1x10-7 mol/L Ang-(1-7) increased the
release of radioactivity elicited by nerve stimulation
(0.5-millisecond-long square-wave pulses at 2 Hz during 2 minutes) by
90% and 60%, respectively. The facilitatory effect on
noradrenergic neurotransmission caused by both peptides
was stereospecifically prevented by
N
-nitro-L-arginine methyl ester
(1x10-4 mol/L), an inhibitor of
nitric oxide synthase that catalyzes the conversion of
L-arginine to nitric oxide, as well as by
1x10-5 mol/L methylene blue, a substance that
inhibits the guanylate cyclase considered as the final
target of nitric oxide action. On the other hand, the precursor of
nitric oxide synthesis, L-arginine
(1x10-3 mol/L), reversed the prevention
produced by N
-nitro-L-arginine
methyl ester on the increased release of norepinephrine
caused by Ang II and Ang-(1-7). The present results suggest that
nitric oxide could be involved in the neuromodulatory function elicited
by both Ang II and Ang-(1-7) in rat atria. The
physiological role of this observation is still
under study.
Key Words: nitric oxide norepinephrine heart rate angiotensin II
This article has been cited by other articles:
![]() |
J. Stegbauer, Y. Kuczka, O. Vonend, I. Quack, L. Sellin, A. Patzak, A. Steege, K. Langnaese, and L. C. Rump Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R421 - R428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stegbauer, V. Oberhauser, O. Vonend, and L. C. Rump Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats Cardiovasc Res, February 1, 2004; 61(2): 352 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Mbaku, L. Zhang, W. J. Pearce, S. P. Duckles, and J. Buchholz Chronic hypoxia alters the function of NOS nerves in cerebral arteries of near-term fetal and adult sheep J Appl Physiol, February 1, 2003; 94(2): 724 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gironacci, M. Vatta, M. Rodriguez-Fermepin, B. E. Fernandez, and C. Pena Angiotensin-(1-7) Reduces Norepinephrine Release Through a Nitric Oxide Mechanism in Rat Hypothalamus Hypertension, June 1, 2000; 35(6): 1248 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Mbaku, L. Zhang, S. P. Duckles, and J. Buchholz Nitric-Oxide Synthase-Containing Nerves Facilitate Adrenergic Transmitter Release in Sheep Middle Cerebral Arteries J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 397 - 402. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |